Results
1
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
1 companies
Oryzon Genomics
Market Cap: €261.0m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€3.17
7D
3.1%
1Y
71.4%